Washington Trust Advisors’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5
Closed -$3 706
2023
Q3
$3 Hold
5
﹤0.01% 672
2023
Q2
$8 Hold
5
﹤0.01% 657
2023
Q1
$10 Hold
5
﹤0.01% 777
2022
Q4
$40 Hold
5
﹤0.01% 780
2022
Q3
$0 Hold
5
﹤0.01% 952
2022
Q2
$1K Hold
5
﹤0.01% 925
2022
Q1
$2K Hold
5
﹤0.01% 972
2021
Q4
$1K Buy
+5
New +$1.37K ﹤0.01% 997

Other funds holding CFRX

Washington Trust Advisors's CFRX Position: Q4 2023 in Review

Washington Trust Advisors sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 5 shares — an estimated $3 sold.

Washington Trust Advisors first reported a position in CFRX in Q4 2021 and held it in 8 quarters. The position peaked at $2K in Q1 2022. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.

  • Washington Trust Advisors reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
  • Washington Trust Advisors sold 5 ContraFect Corporation shares in Q4 2023, an estimated $3.
  • Washington Trust Advisors first reported a position in ContraFect Corporation in Q4 2021 and held it in 8 quarters.
  • Washington Trust Advisors's ContraFect Corporation position peaked at $2K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.

Based on Washington Trust Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.